Related Experiment Videos
[Metabolic disorders in Huntington's chorea].
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)
|January 1, 1978
Summary
Biochemical studies in Huntington's chorea patients revealed decreased glucose tolerance and lower uric acid levels. Cholesterol increased in some, while copper and ceruloplasmin remained within normal ranges, offering insights into the disease's metabolic profile.
Area of Science:
- Biochemistry
- Neurodegenerative Diseases
Context:
- Huntington's chorea is a progressive neurodegenerative disorder.
- Biochemical alterations are often observed in patients with neurodegenerative conditions.
Purpose:
- To investigate the biochemical profile of patients with Huntington's chorea.
- To identify potential metabolic markers associated with the disease.
Summary:
- Biochemical studies in 42 Huntington's chorea patients showed decreased glucose tolerance and reduced serum/urinary uric acid.
- Elevated blood serum cholesterol was noted in some patients.
- Ceruloplasmin activity and copper levels in serum and urine were within normal ranges.
Impact:
- These findings highlight specific metabolic disturbances in Huntington's chorea.
- Understanding these biochemical changes may aid in developing diagnostic or therapeutic strategies.
- Further research can explore the role of these metabolic alterations in disease progression.